ES2037781T3 - Composicion farmaceutica para administracion intrarrectal de una calcitonina y formas de dosificacion unitarias preparadas de estas. - Google Patents
Composicion farmaceutica para administracion intrarrectal de una calcitonina y formas de dosificacion unitarias preparadas de estas.Info
- Publication number
- ES2037781T3 ES2037781T3 ES198888114598T ES88114598T ES2037781T3 ES 2037781 T3 ES2037781 T3 ES 2037781T3 ES 198888114598 T ES198888114598 T ES 198888114598T ES 88114598 T ES88114598 T ES 88114598T ES 2037781 T3 ES2037781 T3 ES 2037781T3
- Authority
- ES
- Spain
- Prior art keywords
- calcitonin
- administration
- less
- intrarrectal
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000055006 Calcitonin Human genes 0.000 title abstract 3
- 108060001064 Calcitonin Proteins 0.000 title abstract 3
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 title abstract 3
- 229960004015 calcitonin Drugs 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- -1 POLYETHYLENE Polymers 0.000 abstract 4
- 239000004698 Polyethylene Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 229920000573 polyethylene Polymers 0.000 abstract 2
- 239000003381 stabilizer Substances 0.000 abstract 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 239000001828 Gelatine Substances 0.000 abstract 1
- HSRJKNPTNIJEKV-UHFFFAOYSA-N Guaifenesin Chemical compound COC1=CC=CC=C1OCC(O)CO HSRJKNPTNIJEKV-UHFFFAOYSA-N 0.000 abstract 1
- 239000004743 Polypropylene Substances 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000007920 enema Substances 0.000 abstract 1
- 229940079360 enema for constipation Drugs 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 229920000159 gelatin Polymers 0.000 abstract 1
- 235000019322 gelatine Nutrition 0.000 abstract 1
- 238000007918 intramuscular administration Methods 0.000 abstract 1
- 229920001155 polypropylene Polymers 0.000 abstract 1
- 229920001451 polypropylene glycol Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
NUEVAS COMPOSICIONES QUE CONTIENEN UN CALCITONIN COMO EL INGREDIENTE ACTIVO SON DESCRITOS QUE SEAN CONVENIENTES PARA LA ADMINISTRACION INTRARECTAL COMO CAPSULAS DE GELATINA BLANDA O MICRO ENEMAS, EN DONDE EL PRINCIPIO ACTIVO, OPCIONALMENTE MEZCLADO CON UN ESTABILIZADOR, ES DISUELTO EN UN VEHICULO LIQUIDO QUE CONTIENE: A) AL MENOS 70% DEL PESO DE UN POLIETILENO O UN GLICOL POLIPROPILENO O UNA MEZCLA DE POLIETILENO O GLICO POLIPROPILENO CON DIFERENTES PESOS MOLECULARES, TENIENDO LA CONSISTENCIA DE UN FLUIDO HOMOGENEO A TEMPERATURA NORMAL Y B) MENOS DEL 15% DEL PESO DE UN AMORTIGUADOR EN UN RANGO PH DESDE 4,5 A 6,5 Y OPCIONALMENTE C) MENOS DEL 15% DEL PESO DE UN ALCOHOL DE 2 A 6 ATOMOS DE CARBONO QUE CONTIENEN DOS O MAS GRUPOS HIDROXI. LOS NUEVOS COMPUESTOS, QUE NO CONTIENEN NINGUN ADITIVO DE ABSORCION, DAN NIVELES DE PLASMA CALCITONIN COMPARABLES A UNA ADMINISTRACION INTRAMUSCULAR CONVENCIONAL.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT22031/87A IT1222734B (it) | 1987-09-25 | 1987-09-25 | Formulaziopne farmaceutiche e forme di dosaggio per la somminaistarzione rettale di calcitonina |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2037781T3 true ES2037781T3 (es) | 1993-07-01 |
Family
ID=11190446
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES198888114598T Expired - Lifetime ES2037781T3 (es) | 1987-09-25 | 1988-09-07 | Composicion farmaceutica para administracion intrarrectal de una calcitonina y formas de dosificacion unitarias preparadas de estas. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4954342A (es) |
| EP (1) | EP0308725B1 (es) |
| JP (1) | JPH01102031A (es) |
| AT (1) | ATE69384T1 (es) |
| DE (1) | DE3866198D1 (es) |
| ES (1) | ES2037781T3 (es) |
| GR (1) | GR3003757T3 (es) |
| IT (1) | IT1222734B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH657779A5 (de) * | 1982-10-05 | 1986-09-30 | Sandoz Ag | Galenische zusammensetzungen enthaltend calcitonin. |
| HU203204B (en) * | 1987-09-15 | 1991-06-28 | Sandoz Ag | Process for producing suppository containing calcitonin and taurocholic acid |
| JP2514249B2 (ja) * | 1989-05-23 | 1996-07-10 | 帝人株式会社 | 安定化されたカルシトニン類医薬組成物 |
| IT1237197B (it) * | 1989-11-16 | 1993-05-26 | Sclavo Spa | Formulazioni farmaceutiche anidre e forme di dosaggio per la somministrazione rettale di calcitonina. |
| IT8922398A0 (it) * | 1989-11-16 | 1989-11-16 | Phidea Spa | Composizioni farmaceutiche ad elevato assorbimento e stabilita', comprendente una calcitonina come sostanza attiva. |
| SE9101381D0 (sv) * | 1991-05-07 | 1991-05-07 | Tomas Moks | Peptide hormone solution |
| US5904935A (en) * | 1995-06-07 | 1999-05-18 | Alza Corporation | Peptide/protein suspending formulations |
| US5726154A (en) * | 1996-06-28 | 1998-03-10 | University Of Utah Research Foundation | Stabilization and oral delivery of calcitonin |
| WO2005037108A2 (en) * | 2003-10-21 | 2005-04-28 | Ramot At Tel Aviv University Ltd. | Compositions and devices including same useful for anastomosis |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4151276A (en) * | 1975-05-12 | 1979-04-24 | Armour Pharmaceutical Company | Method of suppressing gastric acid secretion by the oral administration of calcitonin |
| US4067960A (en) * | 1975-06-20 | 1978-01-10 | R. P. Scherer Limited | Pharmaceutical compositions containing cardiac glycoside |
| DE3171774D1 (en) * | 1980-03-31 | 1985-09-19 | Teijin Ltd | Pharmaceutical composition for intrarectal administration, and suppository prepared therefrom |
| US4618598A (en) * | 1982-04-12 | 1986-10-21 | Duke University | Method of regulating hormone function or release |
| DE3307353C2 (de) * | 1983-03-02 | 1985-01-31 | R.P. Scherer GmbH, 6930 Eberbach | Polyethylenglykolhaltige Weichgelatinekapsel und Verfahren zu ihrer Herstellung |
| JPS59163313A (ja) * | 1983-03-09 | 1984-09-14 | Teijin Ltd | 経鼻投与用ペプチドホルモン類組成物 |
| US4486412A (en) * | 1983-03-15 | 1984-12-04 | Pharmacaps, Inc. | Encapsulated antacid dispersions |
| US4639338A (en) * | 1984-08-06 | 1987-01-27 | Ciba-Geigy Corporation | Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate |
-
1987
- 1987-09-25 IT IT22031/87A patent/IT1222734B/it active
-
1988
- 1988-09-07 AT AT88114598T patent/ATE69384T1/de active
- 1988-09-07 EP EP88114598A patent/EP0308725B1/en not_active Expired - Lifetime
- 1988-09-07 DE DE8888114598T patent/DE3866198D1/de not_active Expired - Fee Related
- 1988-09-07 ES ES198888114598T patent/ES2037781T3/es not_active Expired - Lifetime
- 1988-09-19 JP JP63232750A patent/JPH01102031A/ja active Pending
- 1988-09-26 US US07/249,776 patent/US4954342A/en not_active Expired - Fee Related
-
1992
- 1992-02-11 GR GR920400179T patent/GR3003757T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE69384T1 (de) | 1991-11-15 |
| EP0308725A3 (en) | 1989-04-26 |
| GR3003757T3 (es) | 1993-03-16 |
| DE3866198D1 (de) | 1991-12-19 |
| IT8722031A0 (it) | 1987-09-25 |
| EP0308725B1 (en) | 1991-11-13 |
| JPH01102031A (ja) | 1989-04-19 |
| IT1222734B (it) | 1990-09-12 |
| EP0308725A2 (en) | 1989-03-29 |
| US4954342A (en) | 1990-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69233150T2 (de) | Fluorchlorkohlenwasserstoffreie Aerosolformulierungen | |
| ES2145115T4 (es) | Composiciones inyectables a base de derivados de taxanos. | |
| BR9917403A (pt) | Composições farmacêuticas orais contendo taxanos, e métodos de tratamento empregando as mesmas | |
| ES2044912T3 (es) | Composiciones farmaceuticas dotadas de actividad secuestrante para los acidos biliares, conteniendo colestiramina como principio activo, y procedimiento para su preparacion. | |
| ES2101330T3 (es) | Composicion farmaceutica para uso topico que contiene un polimero cationico reticulado y un eter alcoxilado. | |
| AR003427A1 (es) | Péptidos relacionados con dolastatina, procedimiento para prepararlos, composiciones farmacéuticas que los contienen y el uso de los mismos para la preparación de dichas composiciones farmacéuticas. | |
| ES2106360T3 (es) | Formulaciones farmaceuticas de aerosol que contienen dipropionato de beclometasona. | |
| ES2037781T3 (es) | Composicion farmaceutica para administracion intrarrectal de una calcitonina y formas de dosificacion unitarias preparadas de estas. | |
| AR018891A1 (es) | Inhaladores presurizados de dosificacion medida y formulaciones farmaceuticas en aerosol | |
| PT98890A (pt) | Processo para a preparacao de composicoes farmaceuticas antiemeticas contendo uma mistura de ondansetron com um agente antiemetico ou tranquilizante | |
| ECSP014076A (es) | Emulsiones estables para productos cosmeticos | |
| US3070499A (en) | Parenteral aqueous solutions of fat soluble vitamins | |
| DE69521693D1 (de) | Taxanderivate enthaltende arzneizubereitungen | |
| ES2036587T3 (es) | Medicamentos para el tratamiento o prevencion del sindrome de abstinencia. | |
| US3265573A (en) | Benzothiadiazinesulfonamide-1, 1-dioxide composition | |
| KR850004389A (ko) | 경피침투가 증진된 생리학적 활성제제의 제조방법 | |
| AR012480A1 (es) | Una unidad de dosis farmaceutica que comprende tibolona, un metodo para elaborarla y el uso de un producto de almidon como vehiculo en unidades dedosis farmaceuticas que comprenden tibolona | |
| KR960013363A (ko) | 국소 투여 가능한 아연 프탈로시아닌 조성물 | |
| PE20011271A1 (es) | Formulaciones que contienen una droga glucocorticoide para el tratamiento de enfermedades broncopulmonares | |
| ES2224755T3 (es) | Formulaciones topicas que comprenden agentes de penetracion en la piel y utilizacion de las mismas. | |
| ES2063815T3 (es) | 2-alquil-3-benzoilbenzofuranos y composiciones farmaceuticas que los contienen. | |
| KR880013574A (ko) | 항콕시듐증 조성물 | |
| AR013163A1 (es) | Uso de composiciones que contienen diclorofenil imidazoldioxolano para la preparacion de un medicamento para tratar la dermatitis seborreica, caspa,psoriasis y acne, composiciones propiamente dichas, y un articulo de fabricacion que contiene dicha composicion | |
| FI962056A (fi) | Uusi farmaseuttinen koostumus stabiilin jauheen valmistamiseksi, joka sisältää asetyylisalisyylihapon ja metoklopramidin yhdistelmän käsittävän aktiivisen aineosan | |
| DE1617629A1 (de) | Verfahren zur Stabilisierung von Bromelin in Arzneimittelzubereitungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 308725 Country of ref document: ES |